{"id": "6nIbF6oAAAAJ", "citedby": 8527, "citedby5y": 4498, "hindex": 51, "hindex5y": 36, "i10index": 104, "i10index5y": 83, "coauthors": [], "name": "Jonathan Serody", "affiliation": "Professor University of North Carolina at Chapel Hill", "interests": ["Immunology", "transplantation"], "cites_per_year": {"1996": 24, "1997": 36, "1998": 34, "1999": 36, "2000": 64, "2001": 91, "2002": 90, "2003": 110, "2004": 126, "2005": 201, "2006": 278, "2007": 276, "2008": 273, "2009": 341, "2010": 328, "2011": 335, "2012": 414, "2013": 410, "2014": 441, "2015": 534, "2016": 559, "2017": 687, "2018": 817, "2019": 1223, "2020": 665}, "publications": [{"bib": {"title": "The immune landscape of cancer", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:gsN89kCJA0AC", "citedby": "612"}, {"bib": {"title": "Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1\u2013dependent mechanism that is up-regulated by interleukin-13", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:lSLTfruPkqcC", "citedby": "396"}, {"bib": {"title": "L-Selectinhi but not the L-selectinlo CD4+ 25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:1yQoGdGgb4wC", "citedby": "372"}, {"bib": {"title": "Leukocyte migration and graft-versus-host disease", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:aqlVkmm33-oC", "citedby": "319"}, {"bib": {"title": "In vitro\u2013differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:u9iWguZQMMsC", "citedby": "311"}, {"bib": {"title": "Intravascular catheter exchange and duration of candidemia", "year": "1995"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_B80troHkn4C", "citedby": "310"}, {"bib": {"title": "Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:yD5IFk8b50cC", "citedby": "280"}, {"bib": {"title": "Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:YFjsv_pBGBYC", "citedby": "262"}, {"bib": {"title": "Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:BwyfMAYsbu0C", "citedby": "185"}, {"bib": {"title": "Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:eflP2zaiRacC", "citedby": "158"}, {"bib": {"title": "In vivo imaging of graft-versus-host-disease in mice", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:UeHWp8X0CEIC", "citedby": "158"}, {"bib": {"title": "T-lymphocyte production of macrophage inflammatory protein-1\u03b1 is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host \u2026", "year": "2000"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:2KloaMYe4IUC", "citedby": "146"}, {"bib": {"title": "Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:NMxIlDl6LWMC", "citedby": "136"}, {"bib": {"title": "Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:e5wmG9Sq2KIC", "citedby": "131"}, {"bib": {"title": "Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:tS2w5q8j5-wC", "citedby": "130"}, {"bib": {"title": "Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone \u2026", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ZHo1McVdvXMC", "citedby": "129"}, {"bib": {"title": "B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:bEWYMUwI8FkC", "citedby": "121"}, {"bib": {"title": "Genomic analysis of immune cell infiltrates across 11 tumor types", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:CHSYGLWDkRkC", "citedby": "116"}, {"bib": {"title": "Ibrutinib treatment ameliorates murine chronic graft-versus-host disease", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:M05iB0D1s5AC", "citedby": "113"}, {"bib": {"title": "The role of lactoferrin as an anti-inflammatory molecule", "year": "1994"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:vDijr-p_gm4C", "citedby": "110"}, {"bib": {"title": "T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery", "year": "2000"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:9ZlFYXVOiuMC", "citedby": "109"}, {"bib": {"title": "CD200 is induced by ERK and is a potential therapeutic target in melanoma", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:eQOLeE2rZwMC", "citedby": "103"}, {"bib": {"title": "CSF-1\u2013dependant donor-derived macrophages mediate chronic graft-versus-host disease", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:XiVPGOgt02cC", "citedby": "102"}, {"bib": {"title": "Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:NJ774b8OgUMC", "citedby": "102"}, {"bib": {"title": "The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:f2IySw72cVMC", "citedby": "94"}, {"bib": {"title": "Interaction of lactoferrin and lipopolysaccharide (LPS): effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced \u2026", "year": "1992"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:eJXPG6dFmWUC", "citedby": "93"}, {"bib": {"title": "The IL-17 differentiation pathway and its role in transplant outcome", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:EYYDruWGBe4C", "citedby": "89"}, {"bib": {"title": "CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Mojj43d5GZwC", "citedby": "83"}, {"bib": {"title": "CD8+ T cells are a biologically relevant source of macrophage inflammatory protein-1\u03b1 in vivo", "year": "1999"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ML0RJ9NH7IQC", "citedby": "83"}, {"bib": {"title": "Blastomycosis in transplant recipients: report of a case and review", "year": "1993"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:TQgYirikUcIC", "citedby": "75"}, {"bib": {"title": "TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:PR6Y55bgFSsC", "citedby": "74"}, {"bib": {"title": "Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:uLbwQdceFCQC", "citedby": "73"}, {"bib": {"title": "Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation.", "year": "1991"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:XvxMoLDsR5gC", "citedby": "72"}, {"bib": {"title": "Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:l7t_Zn2s7bgC", "citedby": "71"}, {"bib": {"title": "Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA \u2026", "year": "2000"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:hFOr9nPyWt4C", "citedby": "71"}, {"bib": {"title": "The effect of oral mucositis on morbidity and mortality in bone marrow transplant", "year": "2003"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:WqliGbK-hY8C", "citedby": "70"}, {"bib": {"title": "CC chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:tOudhMTPpwUC", "citedby": "67"}, {"bib": {"title": "CC chemokine receptor 5 on stromal cells promotes pulmonary metastasis", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:fEOibwPWpKIC", "citedby": "67"}, {"bib": {"title": "Transfection of macrophage inflammatory protein 1\u03b1 into B16 F10 melanoma cells inhibits growth of pulmonary metastases but not subcutaneous tumors", "year": "2002"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:HtEfBTGE9r8C", "citedby": "66"}, {"bib": {"title": "Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:7PzlFSSx8tAC", "citedby": "63"}, {"bib": {"title": "A novel viral system for generating antigen-specific T cells", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:VLnqNzywnoUC", "citedby": "63"}, {"bib": {"title": "Increased BCR responsiveness in B cells from patients with chronic GVHD", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:D_sINldO8mEC", "citedby": "62"}, {"bib": {"title": "Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:q3oQSFYPqjQC", "citedby": "60"}, {"bib": {"title": "Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation", "year": "2000"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:L8Ckcad2t8MC", "citedby": "60"}, {"bib": {"title": "Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:anf4URPfarAC", "citedby": "59"}, {"bib": {"title": "GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:7T2F9Uy0os0C", "citedby": "59"}, {"bib": {"title": "Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:PoWvk5oyLR8C", "citedby": "56"}, {"bib": {"title": "Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:8k81kl-MbHgC", "citedby": "56"}, {"bib": {"title": "Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-\u03b2 production", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:5Ul4iDaHHb8C", "citedby": "55"}, {"bib": {"title": "Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:JQOojiI6XY0C", "citedby": "55"}, {"bib": {"title": "Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:dTyEYWd-f8wC", "citedby": "53"}, {"bib": {"title": "Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:K3LRdlH-MEoC", "citedby": "49"}, {"bib": {"title": "Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Y0pCki6q_DkC", "citedby": "47"}, {"bib": {"title": "Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:4JMBOYKVnBMC", "citedby": "47"}, {"bib": {"title": "Murine T Lymphocytes Incapable of Producing Macrophage Inhibitory Protein-1\ue700 Are Impaired in Causing Graft-Versus-Host Disease Across a Class I But Not Class II Major \u2026", "year": "1999"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:LkGwnXOMwfcC", "citedby": "46"}, {"bib": {"title": "Attenuation of acute graft-versus-host disease in the absence of the transcription factor ROR\u03b3t", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:geHnlv5EZngC", "citedby": "45"}, {"bib": {"title": "Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:g5m5HwL7SMYC", "citedby": "45"}, {"bib": {"title": "Prevention of infections in bone marrow transplant recipients", "year": "1997"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:0EnyYjriUFMC", "citedby": "45"}, {"bib": {"title": "Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:JoZmwDi-zQgC", "citedby": "44"}, {"bib": {"title": "Lung adenocarcinoma and squamous cell carcinoma gene expression subtypes demonstrate significant differences in tumor immune landscape", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:YsMSGLbcyi4C", "citedby": "42"}, {"bib": {"title": "Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:HE397vMXCloC", "citedby": "41"}, {"bib": {"title": "Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1\u03b1 (CCL3) after allogeneic BMT in mice", "year": "2003"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:4fKUyHm3Qg0C", "citedby": "39"}, {"bib": {"title": "A dual immunotherapy nanoparticle improves T\u2010cell activation and cancer immunotherapy", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:kuK5TVdYjLIC", "citedby": "38"}, {"bib": {"title": "Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:WbkHhVStYXYC", "citedby": "38"}, {"bib": {"title": "CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:2osOgNQ5qMEC", "citedby": "38"}, {"bib": {"title": "Chemomobilization with etoposide is highly effective in patients with multiple myeloma and overcomes the effects of age and prior therapy", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:maZDTaKrznsC", "citedby": "38"}, {"bib": {"title": "Host absence of CCR5 potentiates dendritic cell vaccination", "year": "2003"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:t7zJ5fGR-2UC", "citedby": "38"}, {"bib": {"title": "B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:4TOpqqG69KYC", "citedby": "37"}, {"bib": {"title": "A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-\u03b2 superfamily", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:9pM33mqn1YgC", "citedby": "36"}, {"bib": {"title": "Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:VaXvl8Fpj5cC", "citedby": "35"}, {"bib": {"title": "A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:KlAtU1dfN6UC", "citedby": "35"}, {"bib": {"title": "A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:a9-T7VOCCH8C", "citedby": "34"}, {"bib": {"title": "Reversing SKI\u2013SMAD4-mediated suppression is essential for TH17 cell differentiation", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:LPZeul_q3PIC", "citedby": "33"}, {"bib": {"title": "Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:zLWjf1WUPmwC", "citedby": "31"}, {"bib": {"title": "Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:FAceZFleit8C", "citedby": "31"}, {"bib": {"title": "Diagnosis and treatment of chronic graft-versus-host disease", "year": "2006"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:a0OBvERweLwC", "citedby": "30"}, {"bib": {"title": "Chemotherapy and stem cell transplantation increase p16INK4a expression, a biomarker of T-cell aging", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Fu2w8maKXqMC", "citedby": "29"}, {"bib": {"title": "Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients", "year": "1997"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:M7yex6snE4oC", "citedby": "28"}, {"bib": {"title": "G protein coupled receptor kinase 3 regulates breast cancer migration, invasion, and metastasis", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:u-x6o8ySG0sC", "citedby": "27"}, {"bib": {"title": "Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V\u2019DJer", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_Ybze24A_UAC", "citedby": "26"}, {"bib": {"title": "Intravesicular cidofovir for the management of BK virus-associated cystitis", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:9Nmd_mFXekcC", "citedby": "26"}, {"bib": {"title": "An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:j3f4tGmQtD8C", "citedby": "25"}, {"bib": {"title": "Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:O3NaXMp0MMsC", "citedby": "25"}, {"bib": {"title": "Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:TIZ-Mc8IlK0C", "citedby": "24"}, {"bib": {"title": "The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:tkaPQYYpVKoC", "citedby": "23"}, {"bib": {"title": "Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:t6usbXjVLHcC", "citedby": "23"}, {"bib": {"title": "Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:LI9QrySNdTsC", "citedby": "21"}, {"bib": {"title": "Fever in immunocompromised patients.", "year": "2000"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:mvPsJ3kp5DgC", "citedby": "21"}, {"bib": {"title": "A clinical and pharmacokinetic study of high-dose carboplatin, paclitaxel, granulocyte colony-stimulating factor, and peripheral blood stem cells in patients with unresectable \u2026", "year": "1995"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:qjMakFHDy7sC", "citedby": "21"}, {"bib": {"title": "A critical role for donor\u2010derived IL\u201022 in cutaneous chronic GVHD", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:rO6llkc54NcC", "citedby": "17"}, {"bib": {"title": "Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:YohjEiUPhakC", "citedby": "17"}, {"bib": {"title": "A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:qUcmZB5y_30C", "citedby": "16"}, {"bib": {"title": "An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:HoB7MX3m0LUC", "citedby": "15"}, {"bib": {"title": "The immunosuppressive tumor environment is the major impediment to successful therapeutic vaccination in Neu transgenic mice", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:SP6oXDckpogC", "citedby": "15"}, {"bib": {"title": "Ex vivo Inhibition of NF\u2010\u03baB Signaling in Alloreactive T\u2010cells Prevents Graft\u2010Versus\u2010Host Disease", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:kh2fBNsKQNwC", "citedby": "15"}, {"bib": {"title": "An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with \u2026", "year": "2003"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ufrVoPGSRksC", "citedby": "15"}, {"bib": {"title": "A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes", "year": "1997"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ZeXyd9-uunAC", "citedby": "14"}, {"bib": {"title": "Alternative tumour-specific antigens", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:bKqednn6t2AC", "citedby": "12"}, {"bib": {"title": "NIAID Mycoses Study Group and the Candidemia Study Group: intravascular catheter exchange and duration of candidemia", "year": "1995"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:HIFyuExEbWQC", "citedby": "12"}, {"bib": {"title": "Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:b1wdh0AR-JQC", "citedby": "11"}, {"bib": {"title": "Peptide/MHC Tetramer\u2013Based Sorting of CD8+ T Cells to a Leukemia Antigen Yields Clonotypes Drawn Nonspecifically from an Underlying Restricted Repertoire", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ZuybSZzF8UAC", "citedby": "11"}, {"bib": {"title": "Clinical responses to CAR. CD30-T cells in patients with CD30+ lymphomas relapsed after multiple treatments including brentuximab vedotin", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:sNmaIFBj_lkC", "citedby": "10"}, {"bib": {"title": "L\u2010selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:e_rmSamDkqQC", "citedby": "10"}, {"bib": {"title": "Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:1sJd4Hv_s6UC", "citedby": "10"}, {"bib": {"title": "Phase II study of high dose cytarabine followed by pembrolizumab in relapsed/refractory acute myeloid leukemia (AML)", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:vbGhcppDl1QC", "citedby": "9"}, {"bib": {"title": "Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:URolC5Kub84C", "citedby": "9"}, {"bib": {"title": "CCR5 expression on CD4 (+) CD25 (+) regulatory T cells plays a critical role in their ability to prevent GVHD.", "year": "2003"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:i2xiXl-TujoC", "citedby": "9"}, {"bib": {"title": "Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:GtLg2Ama23sC", "citedby": "8"}, {"bib": {"title": "Targeting the canonical nuclear factor-\u03baB pathway with a high-potency IKK2 inhibitor improves outcomes in a mouse model of idiopathic pneumonia syndrome", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:abG-DnoFyZgC", "citedby": "8"}, {"bib": {"title": "Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilization", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:uc_IGeMz5qoC", "citedby": "8"}, {"bib": {"title": "Bacterial sepsis and GI tract GVHD: more commensal than you think", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ns9cj8rnVeAC", "citedby": "8"}, {"bib": {"title": "Reactivation of cytomegalovirus infection in critically ill immunocompetent patients", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:eq2jaN3J8jMC", "citedby": "8"}, {"bib": {"title": "T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:dfsIfKJdRG4C", "citedby": "7"}, {"bib": {"title": "Altered T\u2010cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:zA6iFVUQeVQC", "citedby": "7"}, {"bib": {"title": "CC chemokine receptor 5 on pulmonary mesenchymal cells promotes experimental metastasis via the induction of erythroid differentiation regulator 1", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:SdhP9T11ey4C", "citedby": "7"}, {"bib": {"title": "Usefulness of the hematopoietic cell transplantation\u2010specific comorbidity index (HCT\u2010CI) in predicting outcomes for adolescents and young adults with hematologic malignancies \u2026", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Zph67rFs4hoC", "citedby": "7"}, {"bib": {"title": "Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in \u2026", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:vRqMK49ujn8C", "citedby": "7"}, {"bib": {"title": "Chemokines and graft-vs.-host disease", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ILKRHgRFtOwC", "citedby": "7"}, {"bib": {"title": "CD4+ cytolytic effectors are inefficient in the clearance of Listeria monocytogenes", "year": "1996"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:08ZZubdj9fEC", "citedby": "7"}, {"bib": {"title": "Thrombocytopenia in allogeneic peripheral blood stem cell collections", "year": "1996"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ClCfbGk0d_YC", "citedby": "7"}, {"bib": {"title": "B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:GFxP56DSvIMC", "citedby": "6"}, {"bib": {"title": "The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:lmc2jWPfTJgC", "citedby": "6"}, {"bib": {"title": "Targeted Rho-associated kinase 2 (ROCK2) inhibition decreases clinical and immune pathology of murine and human chronic GVHD through Stat3-dependent mechanism", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:NXb4pA-qfm4C", "citedby": "6"}, {"bib": {"title": "Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:pqnbT2bcN3wC", "citedby": "6"}, {"bib": {"title": "Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:r_AWSJRzSzQC", "citedby": "5"}, {"bib": {"title": "Genomics reveal potential biomarkers of response to pembrolizumab after high dose cytarabine in an ongoing phase II trial in relapsed/refractory AML", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:DUooU5lO8OsC", "citedby": "5"}, {"bib": {"title": "GVHD and miR: good things in small packages", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:MXK_kJrjxJIC", "citedby": "5"}, {"bib": {"title": "B cells from patients with chronic GVHD signal via the AKT-driven survival and metabolic fitness pathway", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Se3iqnhoufwC", "citedby": "5"}, {"bib": {"title": "A phase 1b/2 study of CD30-specific chimeric antigen receptor T-cell (CAR-T) therapy in combination with bendamustine in patients with CD30+ Hodgkin and non-Hodgkin lymphoma.", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ipzZ9siozwsC", "citedby": "4"}, {"bib": {"title": "A selective and potent rock 2 inhibitor (KD025) decreases human STAT3-dependent IL-21 and IL-17 production and experimental chronic graft-versus-host disease (cGVHD)", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:BqipwSGYUEgC", "citedby": "4"}, {"bib": {"title": "Absence of CCR5 on donor T cells accelerates GVHD.", "year": "2002"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:UHK10RUVsp4C", "citedby": "4"}, {"bib": {"title": "The control of cytomegalovirus infection: chemotherapy", "year": "1993"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:u5HHmVD_uO8C", "citedby": "4"}, {"bib": {"title": "Receptor-mediated uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical", "year": "1990"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:0N-VGjzr574C", "citedby": "4"}, {"bib": {"title": "Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (\u2265 65 Years \u2026", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:nZcligLrVowC", "citedby": "3"}, {"bib": {"title": "Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:yqoGN6RLRZoC", "citedby": "3"}, {"bib": {"title": "Targeting PI 3K\u03b4 function for amelioration of murine chronic graft\u2010versus\u2010host disease", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:OTTXONDVkokC", "citedby": "3"}, {"bib": {"title": "A Phase Ib/II Study of Anti-CD30 Chimeric Antigen Receptor T Cells for Relapsed/Refractory CD30+ Lymphomas", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:6ZxmRoH8BuwC", "citedby": "3"}, {"bib": {"title": "Concurrent Disseminated Nocardiosis and GI Mucormycosis in a Stem-Cell Transplantation Recipient", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:RYcK_YlVTxYC", "citedby": "3"}, {"bib": {"title": "Targeting BCL6 and Germinal Centers (GCs) in Chronic Graft-Versus-Host Disease (cGVHD) Using Direct and Epigenomic Therapies", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:b0M2c_1WBrUC", "citedby": "3"}, {"bib": {"title": "Identification of an AUC of 7603 Umol\u2217 Min/Hr Per Day X 4 Days as the Maximum Tolerated Dose (MTD) of IV Continuous Infusion (CI) Busulfan (BU) with Fixed Dose Fludarabine (FLU \u2026", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:hC7cP41nSMkC", "citedby": "3"}, {"bib": {"title": "The role of CD4+ CD25+ T regulatory (Treg) cells in allogeneic bone marrow transplantation", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:S16KYo8Pm5AC", "citedby": "3"}, {"bib": {"title": "Immune Response of \u03b22-Microglobulin-Deficient Mice to Pathogens", "year": "1998"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:LjlpjdlvIbIC", "citedby": "3"}, {"bib": {"title": "Minimal PD-1 expression in mouse and human NK cells under diverse conditions", "year": "2020"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:nVrZBo8bIpAC", "citedby": "2"}, {"bib": {"title": "Dendritic cell expression of retinal aldehyde dehydrogenase-2 controls graft-versus-host disease lethality", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:QYdC8u9Cj1oC", "citedby": "2"}, {"bib": {"title": "Phase I/II trial of dose-escalated busulfan delivered by prolonged continuous infusion in allogeneic transplant patients", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:p2g8aNsByqUC", "citedby": "2"}, {"bib": {"title": "High-throughput immunoglobulin heavy chain variable region repertoire analysis of CD27+ B cell subsets from patients with chronic GVHD", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:3s1wT3WcHBgC", "citedby": "2"}, {"bib": {"title": "Predictability and costs associated with good and poor mobilizers using a combination of VP-16 and G-CSF for peripheral blood stem cell (PBSC) mobilization and collection", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ruyezt5ZtCIC", "citedby": "2"}, {"bib": {"title": "Alloimmune Retinopathy Associated with Antibodies to Transducin-\u03b1 as a Complication of Chronic Graft-Versus-Host Disease", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:z_wVstp3MssC", "citedby": "2"}, {"bib": {"title": "Fixed dose G-CSF post autologous peripheral blood stem cell transplantation (PBSCT) permits utilization of lower doses of growth factor without compromising engraftment.", "year": "1998"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:AvfA0Oy_GE0C", "citedby": "2"}, {"bib": {"title": "Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD", "year": "2020"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:fbc8zXXH2BUC", "citedby": "1"}, {"bib": {"title": "Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:8xutWZnSdmoC", "citedby": "1"}, {"bib": {"title": "Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:kz9GbA2Ns4gC", "citedby": "1"}, {"bib": {"title": "Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:k8Z6L05lTy4C", "citedby": "1"}, {"bib": {"title": "Development of subtype specific mouse models of bladder cancer", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:35r97b3x0nAC", "citedby": "1"}, {"bib": {"title": "Spatial-temporal delivery of OX40 agonist and PD-1 inhibitor using nanoparticles improves therapeutic efficacy of cancer immunotherapy", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:mVmsd5A6BfQC", "citedby": "1"}, {"bib": {"title": "Selective ROCK2 inhibitor reverses experimental chronic graft-versus-host disease via concurrent regulation of STAT3/STAT5 phosphorylation (TRAN1P. 933)", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_xSYboBqXhAC", "citedby": "1"}, {"bib": {"title": "Plasticity of Th17 Cells and Conversion to Th1 Cells during Acute GvHD", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:2P1L_qKh6hAC", "citedby": "1"}, {"bib": {"title": "BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:4MWp96NkSFoC", "citedby": "1"}, {"bib": {"title": "Germinal center generation and maintenance by T follicular helper cells is required for the development of chronic GVHD associated bronchiolitis obliterans in a preclinical model", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:J-pR_7NvFogC", "citedby": "1"}, {"bib": {"title": "IL-22 Is Critical To The Pathogenesis Of Cutaneous Gvhd Mediated By Th17 Cells", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:35N4QoGY0k4C", "citedby": "1"}, {"bib": {"title": "One Is Better than Two: TCR Pairing and GVHD", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:bnK-pcrLprsC", "citedby": "1"}, {"bib": {"title": "Increased BLNK and Syk in B cells from chronic graft-versus-host disease patients: Identification of novel therapeutic targets", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:roLk4NBRz8UC", "citedby": "1"}, {"bib": {"title": "RNA-Seq Expression Profiling of AML Stem Cells Reveals Differential Expression of Lineage Differentiation Markers and Novel Splice Variants.", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:RGFaLdJalmkC", "citedby": "1"}, {"bib": {"title": "Bone Marrow Stromal Cells Inhibit Apoptosis of Chronic Lymphocytic Leukemia Cells (CLL) by Expressing Erythroid Differentiation Regulator 1 (ERDR1)", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:yB1At4FlUx8C", "citedby": "1"}, {"bib": {"title": "G Protein Coupled Receptor Kinase 3 (GRK3) Negatively Regulates CXCL12/CXCR4 Signaling and Tumor Migration in Breast Cancer", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:P5F9QuxV20EC", "citedby": "1"}, {"bib": {"title": "The Absence of CC-Chemokine Receptor 8 on Donor Regulatory T Cells Impairs Their Ability to Prevent Lethal Acute Gvhd.", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:N5tVd3kTz84C", "citedby": "1"}, {"bib": {"title": "Bone marrow myeloid-derived suppressor cells (MDSC) inhibit graft versus host disease (GVHD) via an Arginase-1 dependant mechanism that is upregulated by IL-13", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:YOwf2qJgpHMC", "citedby": "1"}, {"bib": {"title": "Pulmonary Stromal Cells Expressing CC-Chemokine Receptor 5 Promote Metastasis Via Erythroid Differentiation Regulator 1.", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:9vf0nzSNQJEC", "citedby": "1"}, {"bib": {"title": "Immunocompromised Status of Patients with Hematologic and Solid Tumor Malignancies: Construction of a Practical Algorithm.", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:B3FOqHPlNUQC", "citedby": "1"}, {"bib": {"title": "Recruitment of donor T cells to secondary lymphoid tissue is enhanced by conditioning therapy and donor T cells/marrow", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:mB3voiENLucC", "citedby": "1"}, {"bib": {"title": "TH17 Cells Mediate Extensive Skin Pathology in Acute GVHD.", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:eMMeJKvmdy0C", "citedby": "1"}, {"bib": {"title": "CD62L Is Not Critical for T Regulatory Cell-Mediated Protection from Lethal Acute GVHD.", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:AXPGKjj_ei8C", "citedby": "1"}, {"bib": {"title": "Symptomatic Improvement Following Intravesicular Cidofovir for the Management of BK Virus Associated Cystitis.", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_kc_bZDykSQC", "citedby": "1"}, {"bib": {"title": "Chronic TLR4 and MyD88 Activation Causes Hepatic Insulin Resistance by Impairing PI3K Inhibition of NFkB.", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:5ugPr518TE4C", "citedby": "1"}, {"bib": {"title": "Mechanisms Responsible for and Strategies To Overcome Bone Marrow (BM) Rejection in Allosensitized Recipients.", "year": "2006"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:-f6ydRqryjwC", "citedby": "1"}, {"bib": {"title": "Phase I study utilizing an intravenous busulfan test dose to prospectively target and determine the maximum tolerated systemic exposure (MTSE) of a continuous intravenous infusion", "year": "2006"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:xtoqd-5pKcoC", "citedby": "1"}, {"bib": {"title": "Methods for treating or preventing GVHD", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:j8SEvjWlNXcC", "citedby": "1"}, {"bib": {"title": "90 hour continuous intravenous busulfan infusion: PK and test dose predictability in allogenic bone marrow transplantation patients", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Ug5p-4gJ2f0C", "citedby": "1"}, {"bib": {"title": "Intravenous busulfan test dose clearance comparison with first and thirteenth dose systemic exposure in allogenic bone marrow transplantation patients", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:SpbeaW3--B0C", "citedby": "1"}, {"bib": {"title": "Ex vivo blockade of NF-kappa B signaling in alloreactive T cells prevents murine graft-versus-host disease (GVHD).", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:FPJr55Dyh1AC", "citedby": "1"}, {"bib": {"title": "The ICOS: ICOSL Costimulatory Pathway Plays an Important Role in GVHD and Bone Marrow (BM) Graft Rejection.", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:iH-uZ7U-co4C", "citedby": "1"}, {"bib": {"title": "Methods for preventing GVHD", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:4DMP91E08xMC", "citedby": "1"}, {"bib": {"title": "Differences in the growth of local versus metastatic melanoma after T regulatory cell depletion", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:dQ2og3OwTAUC", "citedby": "1"}, {"bib": {"title": "In vivo imaging of graft-versus-host-disease (GVHD) in mice.", "year": "2003"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:dhFuZR0502QC", "citedby": "1"}, {"bib": {"title": "Non-myeloablative transplants using cyclophosphamide (CY) and fluadarabine (FL) with G-CSF stimulated bone marrow.", "year": "2001"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:M3NEmzRMIkIC", "citedby": "1"}, {"bib": {"title": "Phase I clinical trial of HER2 peptide-pulsed autologous dendritic cells in patients with metastatic breast cancer (MBC).", "year": "2001"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:5qfkUJPXOUwC", "citedby": "1"}, {"bib": {"title": "Infection in the immunocompromised host", "year": "1998"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:NhqRSupF_l8C", "citedby": "1"}, {"bib": {"title": "Inhibition of Inositol kinase B controls acute and chronic graft-versus-host disease", "year": "2020"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:F9fV5C73w3QC", "citedby": "0"}, {"bib": {"title": "Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients", "year": "2020"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:lvd772isFD0C", "citedby": "0"}, {"bib": {"title": "Using RNA Sequencing to Characterize the Tumor Microenvironment", "year": "2020"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:yMeIxYmEMEAC", "citedby": "0"}, {"bib": {"title": "Third Party Type 2 Innate Lymphoid Cells Treat and Prevent GI Tract Acute GvHD", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Ehil0879vHcC", "citedby": "0"}, {"bib": {"title": "Retrospective Cohort Study Analyzing the Safety and Efficacy of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:P7Ujq4OLJYoC", "citedby": "0"}, {"bib": {"title": "Epigenetic Plasticity of Type II Innate Lymphoid Cells in the Lower Gastrointestinal Tract", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:OP4eGU-M3BUC", "citedby": "0"}, {"bib": {"title": "Methods for subtyping of lung squamous cell carcinoma", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ZzlSgRqYykMC", "citedby": "0"}, {"bib": {"title": "Methods for subtyping of lung adenocarcinoma", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_OXeSy2IsFwC", "citedby": "0"}, {"bib": {"title": "Licensing of CAR-T cell persistence and function by STING agonist in breast cancer", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Aul-kAQHnToC", "citedby": "0"}, {"bib": {"title": "Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:LhH-TYMQEocC", "citedby": "0"}, {"bib": {"title": "Comprehensive analysis with interactive exploration of immune response signatures in 10,000 tumor samples", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:cWzG1nlazyYC", "citedby": "0"}, {"bib": {"title": "Inhibiting EZH2 function prevents and treats chronic graft vs host disease (cGVHD) by disrupting germinal center formation and plasma cell maturation", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:OR75R8vi5nAC", "citedby": "0"}, {"bib": {"title": "B7-H4 expression in donor T cells and host cells negatively regulates acute graftversus-host disease lethality", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ODE9OILHJdcC", "citedby": "0"}, {"bib": {"title": "PD-1 checkpoint therapy promotes pro-survival phenotype in regulatory T cells in a model of claudin-low breast cancer", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:yFnVuubrUp4C", "citedby": "0"}, {"bib": {"title": "Utilizing Data to Modify Standard Operating Procedures and Improve Outcomes: Evaluating Complications after Donor Lymphocyte Infusions in Allogeneic Stem Cell Transplant Recipients", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_5tno0g5mFcC", "citedby": "0"}, {"bib": {"title": "Abstract GS1-05: Apobec3 induced mutagenesis sensitizes murine models of triple negative breast cancer to immunotherapy by activating B-cells and CD4+ T-cells", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:9c2xU6iGI7YC", "citedby": "0"}, {"bib": {"title": "Abstract P2-09-05: LCCC 1525: A phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer (mTNBC)", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:IUKN3-7HHlwC", "citedby": "0"}, {"bib": {"title": "Apobec3 induced mutagenesis sensitizes murine models of triple negative breast cancer to immunotherapy by activating B-cells and CD4+ T-cells", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:KbBQZpvPDL4C", "citedby": "0"}, {"bib": {"title": "LCCC 1525: A phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer (mTNBC)", "year": "2019"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:fFSKOagxvKUC", "citedby": "0"}, {"bib": {"title": "Combination Immunotherapy: A Dual Immunotherapy Nanoparticle Improves T\u2010Cell Activation and Cancer Immunotherapy (Adv. Mater. 25/2018)", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:tuHXwOkdijsC", "citedby": "0"}, {"bib": {"title": "Myeloid Leukemia Vaccines", "year": "2018"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:tYavs44e6CUC", "citedby": "0"}, {"bib": {"title": "A Novel Process for the Expansion of Functional Human ILC2 Cells for GCHD Prevention", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:-_dYPAW6P2MC", "citedby": "0"}, {"bib": {"title": "Bim Regulates the Survival and Suppressive Capability of CD8+ Foxp3+ Regulatory T Cells during Graft Versus Host Disease", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:HDshCWvjkbEC", "citedby": "0"}, {"bib": {"title": "Phase 2 trial exploring allogeneic vaccine therapy in late-stage, second-line non-small cell lung cancer", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:mNrWkgRL2YcC", "citedby": "0"}, {"bib": {"title": "Regulatory T cell recruitment limits the effectiveness of checkpoint inhibition for claudin-low breast cancer", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:1qzjygNMrQYC", "citedby": "0"}, {"bib": {"title": "LCCC 1525: Combination immunotherapy with cyclophosphamide plus pembrolizumab in patients with advanced triple negative breast cancer (TNBC).", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Z5m8FVwuT1cC", "citedby": "0"}, {"bib": {"title": "Retrospective Analysis of Survival after Allogeneic Bone Marrow Transplantation in Adult Patients with High-Risk Psychosocial Characteristics", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:kzcrU_BdoSEC", "citedby": "0"}, {"bib": {"title": "Increased Immune Suppression is Associated with Worse Overall Survival in Allogeneic Hematopoietic Cell Transplant Patients Receiving Reduced Intensity Continuous Infusion Busulfan", "year": "2017"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:isC4tDSrTZIC", "citedby": "0"}, {"bib": {"title": "Pirfenidone Reverses Murine Chronic Graft Versus Host Disease", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:xtRiw3GOFMkC", "citedby": "0"}, {"bib": {"title": "Mechanism and Activity of ILC2 Cells Post Allo-BMT", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:NaGl4SEjCO4C", "citedby": "0"}, {"bib": {"title": "Expression subtypes of lung adenocarcinoma and squamous cell carcinoma reveal a varied immune landscape and unique somatic genetic features suggesting differential response to \u2026", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ye4kPcJQO24C", "citedby": "0"}, {"bib": {"title": "Compositions and methods for preventing and treating graft versus host disease", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:g3aElNc5_aQC", "citedby": "0"}, {"bib": {"title": "Immune cell activation among lung adenocarcinoma and squamous cell carcinoma intrinsic subtypes and CD274 (PD-L1) expression.", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:TFP_iSt0sucC", "citedby": "0"}, {"bib": {"title": "Protein Kinase C-\u03b8 and vimentin modulate multiple facets of Regulatory T-cell function.", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:PELIpwtuRlgC", "citedby": "0"}, {"bib": {"title": "Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging", "year": "2016"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:mlAyqtXpCwEC", "citedby": "0"}, {"bib": {"title": "Absence of Coronin 1B in Donor T Cells Diminishes Acute Gvhd By Impairing T Cell Accumulation in Secondary Lymphoid Tissue", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:hkOj_22Ku90C", "citedby": "0"}, {"bib": {"title": "Role of PD-1/PD-L1 in Acute and Chronic Graft Versus Host Disease", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:EUQCXRtRnyEC", "citedby": "0"}, {"bib": {"title": "Protein Kinase C-Theta Interacts with mTORC2 and Vimentin to Limit Regulatory T-Cell Function", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:bFI3QPDXJZMC", "citedby": "0"}, {"bib": {"title": "Effect of Anti-Fungal Prophylaxis on the Fungal Mycobiome after Allogeneic Bone Marrow Transplantation", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ldfaerwXgEUC", "citedby": "0"}, {"bib": {"title": "Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for \u2026", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:70eg2SAEIzsC", "citedby": "0"}, {"bib": {"title": "Loss of programmed death ligand-1 expression on donor T cells lessens acute graft-versus-host disease lethality", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:UebtZRa9Y70C", "citedby": "0"}, {"bib": {"title": "Chronic GvHD Is Characterized By Impaired B Cell Development in the Bone Marrow", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_FxGoFyzp5QC", "citedby": "0"}, {"bib": {"title": "Impact of tumor-infiltrating B-cell clonal diversity on response to neoadjuvant therapy in triple negative and HER2+ breast cancer treated on CALGB (Alliance) 40601 and 40603", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:2VqYfGB8ITEC", "citedby": "0"}, {"bib": {"title": "Abstract PD1-2: Impact of tumor-infiltrating B-cell clonal diversity on response to neoadjuvant therapy in triple negative and HER2+ breast cancer treated on CALGB (Alliance \u2026", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:J_g5lzvAfSwC", "citedby": "0"}, {"bib": {"title": "Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease", "year": "2015"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:JV2RwH3_ST0C", "citedby": "0"}, {"bib": {"title": "Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:UxriW0iASnsC", "citedby": "0"}, {"bib": {"title": "The Contribution of Fibrocytes to the Progression of Multiple Myeloma", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:k_IJM867U9cC", "citedby": "0"}, {"bib": {"title": "Infusion of Ex Vivo Activated Donor Type 2 Innate Lymphoid Cells Inhibit Th1 Activity and Reduces Acute Graft-Versus-Host Disease", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:kNdYIx-mwKoC", "citedby": "0"}, {"bib": {"title": "CSF-1-dependant Bone Marrow Derived Macrophages Mediate Chronic Graft-Versus-Host Disease", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_FM0Bhl9EiAC", "citedby": "0"}, {"bib": {"title": "Ibrutinib can reverse established chronic graft-versus-host disease, which is dependent upon IL-2 inducible T-cell kinase (ITK) and Bruton's tyrosine kinase (BTK)-driven \u2026", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:W5xh706n7nkC", "citedby": "0"}, {"bib": {"title": "Therapeutic treatment of multi-organ system, obstructive pulmonary and scleradermatous chronic graft-versus-host disease with the BTK and ITK inhibitor Ibrutinib (TRAN3P. 873)", "year": "2014"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:IWHjjKOFINEC", "citedby": "0"}, {"bib": {"title": "Aryl Hydrocarbon Receptor Deficient Donor T Cells Display Decreased Migration and Cause Reduced Or Enhanced Graft-Versus-Host Diseases In Different Transplant Models", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:vV6vV6tmYwMC", "citedby": "0"}, {"bib": {"title": "Significance of myeloid-derived suppressor cells in squamous cell carcinoma of the head and neck.", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:dshw04ExmUIC", "citedby": "0"}, {"bib": {"title": "Immune Response of 32-Microglobulin-Deficient Mice", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:sSrBHYA8nusC", "citedby": "0"}, {"bib": {"title": "Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation", "year": "2013"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:pyW8ca7W8N0C", "citedby": "0"}, {"bib": {"title": "Feasibility and Prognostic Value of VO2peak in Patients Undergoing Hematopoietic Cell Transplantation (HCT)", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:nb7KW1ujOQ8C", "citedby": "0"}, {"bib": {"title": "Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT)", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_Qo2XoVZTnwC", "citedby": "0"}, {"bib": {"title": "Fibrocytes promote metastasis by recruiting Ly-6C+ myeloid cells", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:r0BpntZqJG4C", "citedby": "0"}, {"bib": {"title": "Beneficial Effect of High-Dose Iv Busulfan (Bu) Delivered by Prolonged Continuous Infusion (CI) on Relapse Rate and Overall Survival (OS) in Matched Related and Unrelated \u2026", "year": "2012"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:86PQX7AUzd4C", "citedby": "0"}, {"bib": {"title": "Beneficial Effect of Escalated Doses of Busulfan (BU) Delivered by Targeted Pharmacokinetics and Prolonged Continuous Infusion on Relapse Free and Overall Survival in Matched \u2026", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:0KyAp5RtaNEC", "citedby": "0"}, {"bib": {"title": "In Vivo Assessment of T Effector, T Regulatory Cell, Dendritic Cell Interaction in Lymphoid Tissue Using Intravital Imaging During Acute GvHD", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:VL0QpB8kHFEC", "citedby": "0"}, {"bib": {"title": "Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide+ G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for \u2026", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:BrmTIyaxlBUC", "citedby": "0"}, {"bib": {"title": "Impaired Donor T Cell Egress From Recipient Lymphoid Tissue Profoundly Diminishes Acute GvHD", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:4OULZ7Gr8RgC", "citedby": "0"}, {"bib": {"title": "Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide plus G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for \u2026", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:R3hNpaxXUhUC", "citedby": "0"}, {"bib": {"title": "Inhibition of Histone Methylation Arrests Ongoing Graft-Versus-Host Diseases in Mice by Selectively Inducing Apoptosis of Alloreactive Effector T Cells", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:M3ejUd6NZC8C", "citedby": "0"}, {"bib": {"title": "Infections fongiques", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:dBIO0h50nwkC", "citedby": "0"}, {"bib": {"title": "TH17 Cells, Proteins Associated with TH17 Polarization, and Their Role in Graft vs. Host Disease", "year": "2011"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_Re3VWB3Y0AC", "citedby": "0"}, {"bib": {"title": "Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of ROR\u03b3t.", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:uWiczbcajpAC", "citedby": "0"}, {"bib": {"title": "Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation.", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Wp0gIr-vW9MC", "citedby": "0"}, {"bib": {"title": "B Cells Are Primed for Survival by BAFF-Driven Bim Degradation In Chronic Graft Versus Host Disease (cGVHD) Patients", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Tyk-4Ss8FVUC", "citedby": "0"}, {"bib": {"title": "Erythroid Differentiation Regulator 1 (ERDR1) From Nurse-Like Cells Promotes the Survival of Chronic Lymphocytic Leukemia Cells", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:IjCSPb-OGe4C", "citedby": "0"}, {"bib": {"title": "Cytomegalovirus reactivation occurs in burn patients and correlates with increased central memory and regulatory T cell populations.(39.32)", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:OcBU2YAGkTUC", "citedby": "0"}, {"bib": {"title": "Efficacy And Safety Of Chemomoblization With VP-16 And G-CSF In Patients (PTS) Undergoing Autologous Stem Cell Transplantation (ASCT) For Multiple Myeloma (MM)", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:edDO8Oi4QzsC", "citedby": "0"}, {"bib": {"title": "The Efficacy And Safety Of VP-16 And G-CSF As A Mobilization Regimen Prior To Autologous Stem Cell Transplantation (ASCT) For Patients (PTS) With Multiple Myeloma (MM) And Lymphoma", "year": "2010"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Dip1O2bNi0gC", "citedby": "0"}, {"bib": {"title": "CCR1 Is Required for Treg-Mediated Protection From Lethal Acute Graft-Versus-Host Disease.", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:epqYDVWIO7EC", "citedby": "0"}, {"bib": {"title": "The Efficacy and Safety of VP-16 and G-CSF as a Mobilization Regimen Prior to Autologous Stem Cell Transplantation (ASCT) for Patients (Pts) with Multiple Myeloma (MM) and \u2026", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:cFHS6HbyZ2cC", "citedby": "0"}, {"bib": {"title": "Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults (AYAs) with hematologic \u2026", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:HbR8gkJAVGIC", "citedby": "0"}, {"bib": {"title": "Prognostic impact of bone marrow CD138 immunohistochemistry (IHC) prior to autologous stem cell transplant (ASCT) for multiple myeloma (MM)", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:blknAaTinKkC", "citedby": "0"}, {"bib": {"title": "In Vivo Effects of Toll-like Receptor Signaling on T-cell Responses for GVHD and GVL", "year": "2009"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:tKAzc9rXhukC", "citedby": "0"}, {"bib": {"title": "The Absence of CCR7 on Donor T Cells Leads to Attenuated Graft-Versus-Host Disease (GVHD) with a Preserved Graft-Versus-Leukemia (GVL) Effect", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:fPk4N6BV_jEC", "citedby": "0"}, {"bib": {"title": "Adhesion Molecule Blockade with the Humanized Anti-LFA-1 Monoclonal Antibody Efalizumab Improves Steroid Refractory Acute and Chronic Graft-Versus-Host Disease of the Skin", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:GnPB-g6toBAC", "citedby": "0"}, {"bib": {"title": "PMCID: PMC419567.", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:u-coK7KVo8oC", "citedby": "0"}, {"bib": {"title": "Influence of glutathione S-transferase A1 genotype on intravenous busulfan pharmacokinetics", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:XoXfffV-tXoC", "citedby": "0"}, {"bib": {"title": "TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Commentary", "year": "2008"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:WF5omc3nYNoC", "citedby": "0"}, {"bib": {"title": "Viral reactivation and disease: A potentially important contributor to morbidity and mortality following severe burn injury", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:hqOjcs7Dif8C", "citedby": "0"}, {"bib": {"title": "Absence of CCR4 Enhances the Function of Expanded Regulatory T-Cells.", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:8AbLer7MMksC", "citedby": "0"}, {"bib": {"title": "Low Incidence of GVHD and Treatment-Related Morbidity (TRM) with Intermediate Doses of Continuous Infusion IV Busulfan and Daily Fludarabine with Individualized Doses of \u2026", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Tiz5es2fbqcC", "citedby": "0"}, {"bib": {"title": "273: Safety and efficacy of high-dose busulfan by 90-hour continuous infusion in hematologic malignancy patients undergoing allogeneic stem cell transplants", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:4fGpz3EwCPoC", "citedby": "0"}, {"bib": {"title": "Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Commentary", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:SeFeTyx0c_EC", "citedby": "0"}, {"bib": {"title": "Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Commentary", "year": "2007"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:9yKSN-GCB0IC", "citedby": "0"}, {"bib": {"title": "In Vivo CpG Administration Accelerates Graft-Versus-Host Disease (GVHD) Lethality by Toll-Like Receptor 9 (TLR9) Ligation of Host Antigen-Presenting Cells (APCs) and Promotes \u2026", "year": "2006"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:XD-gHx7UXLsC", "citedby": "0"}, {"bib": {"title": "FTY720 Inhibits Graft-Versus-Host Disease (GVHD) and Allogeneic Bone Marrow (BM) Graft Rejection Independent of Effects on T Cell Egress from Lymphoid Tissue.", "year": "2006"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:wbdj-CoPYUoC", "citedby": "0"}, {"bib": {"title": "Mitoxantrone and Melphalan as Conditioning Regimen for Autologous Stem Cell Transplant for Multiple Myeloma.", "year": "2006"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:d1gkVwhDpl0C", "citedby": "0"}, {"bib": {"title": "COLL 43-Applying imprint lithography (PRINT) for the generation of shape-specific, targeted nanocarriers in medicine", "year": "2006"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:L7CI7m0gUJcC", "citedby": "0"}, {"bib": {"title": "COLL 219-Utilizing the emerging imprint lithography technique (PRINT) for the fabrication of shape-specific organic nanoparticles for applications in nanomedicine", "year": "2006"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:VOx2b1Wkg3QC", "citedby": "0"}, {"bib": {"title": "The CCCR deletion mutation and graft-versus-host disease", "year": "2006"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:V3AGJWp-ZtQC", "citedby": "0"}, {"bib": {"title": "Clinical and Pharmacokinetic Results of a Four-Day Continuous Infusion of Full-Dose Busulfan in Patients (pts) Undergoing Matched Related (MRD) or Unrelated (MUD) Stem Cell \u2026", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:LO7wyVUgiFcC", "citedby": "0"}, {"bib": {"title": "Long Term Effects on GVHD and Survival Following the Use of G-CSF Stimulated Bone Marrow Versus G-CSF Mobilized Peripheral Blood Stem Cells in HLA Matched Sibling Transplant.", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ZfRJV9d4-WMC", "citedby": "0"}, {"bib": {"title": "High response rate but significant toxicity with sequential high-dose ifosfamide (I), carboplatin (C), and etoposide (E) with rituximab for relapsed Hodgkin\u2019s (HD) and large \u2026", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:u_35RYKgDlwC", "citedby": "0"}, {"bib": {"title": "Chemokine receptor 5 promotes pulmonary metastasis", "year": "2005"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:rmuvC79q63oC", "citedby": "0"}, {"bib": {"title": "Chemokines and Graft-vs.-Host", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:HtS1dXgVpQUC", "citedby": "0"}, {"bib": {"title": "KENNETH R. COOKE", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:DJbcl8HfkQkC", "citedby": "0"}, {"bib": {"title": "Ex Vivo Blockade of NF-[dappa] B Signaling in Alloreactive T Cells Prevents Murine Graft-Versus-Host Disease (GVHD).", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:4vMrXwiscB8C", "citedby": "0"}, {"bib": {"title": "BK virturia in patients undergoing allogeneic hematopoietic stem cell transplantation: Increased incidence in patients receiving alemtuzumab (ALEM) as conditioning therapy and \u2026", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:_axFR9aDTf0C", "citedby": "0"}, {"bib": {"title": "BK Viruria in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Increased Incidence in Patients Receiving Alemtuzumab (ALEM) as Conditioning Therapy and \u2026", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:WZBGuue-350C", "citedby": "0"}, {"bib": {"title": "High Relapse Rate Following Alemtuzamab Use in Allogeneic Transplants for Myeloid Hematologic Malignancies.", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:qxL8FJ1GzNcC", "citedby": "0"}, {"bib": {"title": "Visualizing Allogeneic Bone Marrow (BM) Graft Rejection.", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:zYLM7Y9cAGgC", "citedby": "0"}, {"bib": {"title": "The role of CD4 (+) 25 (+) T regulatory cells in allogeneic bone marrow transplantation.", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:ULOm3_A8WrAC", "citedby": "0"}, {"bib": {"title": "CELLULAR IMMUNOLOGY AND IMMUNE REGULATION-Differential Roles for CCR5 Expression on Donor T Cells during Graft-versus-Host Disease Based on Pretransplant Conditioning", "year": "2004"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:5nxA0vEk-isC", "citedby": "0"}, {"bib": {"title": "Combined infusion of peripheral blood stem cells (PBSC) plus bone marrow (BM) in poorly mobilizing patients undergoing high-dose therapy (HDT) and autologous stem cell \u2026", "year": "2003"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:oNZyr7d5Mn4C", "citedby": "0"}, {"bib": {"title": "Ex vivo blockade of NF-kB signaling in alloreactive T cells prevents murine graft-versus-host disease (GVHD)", "year": "2003"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:q3CdL3IzO_QC", "citedby": "0"}, {"bib": {"title": "Effects of a truncated erythropoietin receptor (tEpoR) transgene on proliferation and function of dendritic cells derived from murine bone marrow.", "year": "2002"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:hCrLmN-GePgC", "citedby": "0"}, {"bib": {"title": "Cytoprotection by amifostine during autologous stem cell transplant for advanced refractory hematologic malignancies.", "year": "2002"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:738O_yMBCRsC", "citedby": "0"}, {"bib": {"title": "Use of prophylactic ganciclovir (G) and CMV antigen (Ag) screening in allogeneic transplant patients (pts) receiving high-dose steroids (HDS).", "year": "2002"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:XiSMed-E-HIC", "citedby": "0"}, {"bib": {"title": "Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor macrophage inflammatory protein-1 alpha (MIP-1 alpha) following allogeneic bone marrow transplant \u2026", "year": "2001"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:PVjk1bu6vJQC", "citedby": "0"}, {"bib": {"title": "Efficacy of peripheral blood stem cell or mobilized marrow transplant in the treatment of refractory multiple myeloma.", "year": "2000"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:W7OEmFMy1HYC", "citedby": "0"}, {"bib": {"title": "Transient impact of stem cell infusion on platelet function.", "year": "1998"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:EkHepimYqZsC", "citedby": "0"}, {"bib": {"title": "Busulfan test dose area under the curve predicts dose required to achieve targeted therapeutic concentration in bone marrow transplant patients", "year": "1998"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:fQNAKQ3IYiAC", "citedby": "0"}, {"bib": {"title": "CD-34 cell mobilization with intermediate dose cyclophosphamide,(CY) paclitaxel (P) and G-CSF.", "year": "1997"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:D03iK_w7-QYC", "citedby": "0"}, {"bib": {"title": "Blockade of T lymphocyte production of the chemokine MIP-1 alpha decreases the severity and time to onset of chronic GVHD across a class I but not class II MHC barrier", "year": "1997"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:QIV2ME_5wuYC", "citedby": "0"}, {"bib": {"title": "A phase I-II study of cyclophosphamide (CY), VP-16, carboplatin (CBDCA), and total body irradiation (TBI) with autologous stem cell transplantation for acute leukemia.", "year": "1996"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:tzM49s52ZIMC", "citedby": "0"}, {"bib": {"title": "Utility of Blood Cultures in Bone Marrow Transplant Patients with Leukopenic Fever: 199", "year": "1996"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:WA5NYHcadZ8C", "citedby": "0"}, {"bib": {"title": "PE \u3068 PVC \u306e\u6df7\u5408\u30d7\u30e9\u30b9\u30c1\u30c3\u30af\u304a\u3088\u3073 PE \u3068 PET \u306e\u6df7\u5408\u30d7\u30e9\u30b9\u30c1\u30c3\u30af\u306e\u71b1\u5206\u89e3\u6cb9\u5316", "year": "1996"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:hMsQuOkrut0C", "citedby": "0"}, {"bib": {"title": "Production of allogeneic leukemia-specific CD4+ lymphocytes in vitro", "year": "1995"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:Y5dfb0dijaUC", "citedby": "0"}, {"bib": {"title": "Phase I/II results of cyclophosphamide (CY) VP-16, carboplatin (CBDCA) and total body irradiation (TBI) with autologous stem cell transplantation for hematologic malignancies", "year": "1995"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:uWQEDVKXjbEC", "citedby": "0"}, {"bib": {"title": "PHAGOCYTES: FREE RADICALS, LACTOFERRIN AND THE LACTOFERRIN RECEPTOR", "year": "1991"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:5awf1xo2G04C", "citedby": "0"}, {"bib": {"title": "PHYSIOLOGIC RESPONSE OF U937 CELLS TO REDOX STRESS-DEMONSTRATION OF NOVEL HEAT-SHOCK PROTEINS", "year": "1990"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:bz8QjSJIRt4C", "citedby": "0"}, {"bib": {"title": "Lactoferrin and monocyte biology", "year": "1990"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:nrtMV_XWKgEC", "citedby": "0"}, {"bib": {"title": "THE MEMORIAL SLOAN-KETTERING EXPERIENCE WITH ALLOGENEIC STEM CELL TRANSPLANTATION FOR T CELL NON-HODGKINS LYMP-HOMAS"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:foquWX3nUaYC", "citedby": "0"}, {"bib": {"title": "THE GRAFT-VERSUS-MYELOMA EFFECT USING NON-MYELOABLATIVE OR REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:-FonjvnnhkoC", "citedby": "0"}, {"bib": {"title": "Antigen-capturing nanoparticles improve the abscopal effect and cancer"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:KUbvn5osdkgC", "citedby": "0"}, {"bib": {"title": "Alter, BP, 147"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:evX43VCCuoAC", "citedby": "0"}, {"bib": {"title": "An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:olpn-zPbct0C", "citedby": "0"}, {"bib": {"title": "Review 417-425 Halofuginone to Treat Fibrosis in Chronic Graft-versus-Host Disease and Scleroderma"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:kRWSkSYxWN8C", "citedby": "0"}, {"bib": {"title": "TLR agonists regulate alloresponses and uncover a critical role for donor"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:OU6Ihb5iCvQC", "citedby": "0"}, {"bib": {"title": "Donor T cell-production of RANTES significantly contributes to the"}, "source": "citations", "id_citations": "6nIbF6oAAAAJ:3fE2CSJIrl8C", "citedby": "0"}]}